In PDAC, a positive PD-L1 expression can be found in approximately 30–40% of cases and is correlated with low tumor-infiltrating lymphocytes, particularly CD8+ cells, and a poor prognosis [66,67]. The gene discussed is CD274; the disease is neoplasm.